Table 1.
Clinicopathological characteristics of GCT patients.
| Variable | N | % |
|---|---|---|
| All patients | 74 | 100.0 |
| Age (years) | ||
| Median (range) | 35 (19–62) | |
| Sex | ||
| Male | 74 | 100.0 |
| Female | 0 | 0.0 |
| Histology | ||
| Seminoma | 20 | 27.0 |
| Nonseminoma | 54 | 73.0 |
| Primary tumor localization | ||
| Testicular | 71 | 91 |
| Extragonadal | 3 | 8.1 |
| IGCCCG risk group | ||
| Good risk | 43 | 58.1 |
| Intermediate risk | 7 | 9.5 |
| Poor risk | 11 | 14.9 |
| Stage IA and IB (adjuvant therapy) | 13 | 17.6 |
| Sites of metastases | ||
| Retroperitoneum | 53 | 71.6 |
| Mediastinum | 10 | 13.5 |
| Lungs | 14 | 18.9 |
| Liver | 6 | 8.1 |
| Brain | 2 | 2.7 |
| Other | 1 | 1.4 |
| Visceral nonpulmonary metastases | 8 | 10.8 |
| No. of metastatic site(s) | ||
| 0 to 1 | 53 | 71.6 |
| >2 | 21 | 28.4 |
| Staging (UICC) | ||
| IA | 2 | 2.7 |
| IB | 11 | 14.9 |
| IS | 5 | 6.8 |
| IIA | 5 | 6.8 |
| IIB | 15 | 20.3 |
| IIC | 6 | 8.1 |
| IIIA | 8 | 10.8 |
| IIIB | 10 | 13.5 |
| IIIC | 12 | 16.2 |
IGCCCG, International Germ Cell Consensus Classification Group; UICC, Union for International Cancer Control.